XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Unaudited Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Statement of Comprehensive Income [Abstract]        
Collaboration revenues $ 3,827 $ 2,578 $ 10,630 $ 6,103
Operating expenses:        
Research and development 19,551 15,557 54,710 38,536
General and administrative 6,620 3,772 22,201 8,407
Total operating expenses 26,171 19,329 76,911 46,943
Operating loss (22,344) (16,751) (66,281) (40,840)
Change in fair value of derivative liability 0 (668) (84) (1,369)
Interest income (expense), net 941 (908) 641 (2,278)
Pre-tax loss (21,403) (18,327) (65,724) (44,487)
Income tax expense 0 0 (197) 0
Net loss $ (21,403) $ (18,327) $ (65,921) $ (44,487)
Share information:        
Net loss per share of common stock, basic (in USD per share) $ (0.53) $ (8.37) $ (2.11) $ (21.14)
Net loss per share of common stock, diluted (in USD per share) $ (0.53) $ (8.37) $ (2.11) $ (21.14)
Weighted-average shares of common stock outstanding, basic (in shares) 40,285,858 2,189,265 31,209,904 2,104,105
Weighted-average shares of common stock outstanding, diluted (in shares) 40,285,858 2,189,265 31,209,904 2,104,105
Comprehensive loss        
Net loss $ (21,403) $ (18,327) $ (65,921) $ (44,487)
Unrealized gain (loss) on marketable securities 108 37 414 (160)
Comprehensive loss $ (21,295) $ (18,290) $ (65,507) $ (44,647)